Qing Zhang

Title: Qing Zhang: Innovator in Plasma Cell Disorder Research

Introduction

Qing Zhang is a notable inventor based in Charlotte, NC, who has made significant contributions to the field of medical research, particularly in the area of plasma cell disorders. With a focus on immunomodulatory derivatives and minimal residual disease, Zhang's work is paving the way for advancements in treatment and diagnosis.

Latest Patents

Zhang holds 2 patents that reflect his innovative approach to addressing complex medical challenges. His latest patents include:

1. **Methods of determining IMiDS resistance in plasma cell disorders** - This invention provides methods for determining immunomodulatory derivatives (IMiDs) resistance in a subject having a plasma cell disorder.

2. **Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma** - This invention offers methods for determining the level or status of minimal residue disease (MRD) in a multiple myeloma (MM) patient. It includes analyzing peripheral natural killer (NK), NK-T, and T cell distribution and/or activation, and quantifying inflammatory cytokines, chemokines, and growth factors in a biological sample obtained from an MM patient to provide a peripheral immune profile. If the peripheral immune profile exceeds a pre-determined threshold, the MM patient is considered positive for MRD.

Career Highlights

Qing Zhang is currently associated with the Charlotte-Mecklenburg Hospital Authority, where he applies his expertise in medical research to improve patient outcomes. His work is instrumental in advancing the understanding of plasma cell disorders and their treatment.

Collaborations

Zhang collaborates with esteemed colleagues such as Saad Z Usmani and Manisha Bhutani, who contribute to the research and development of innovative solutions in the field.

Conclusion

Qing Zhang's contributions to the field of plasma cell disorder research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire innovation and improve patient care in the medical community.